Alan Mast
Affiliations: | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Pathology, BiochemistryGoogle:
"Alan Mast"Mean distance: (not calculated yet)
Children
Sign in to add trainee| James M. Lockett | grad student | 2003 | UTHSC |
| Anna C. Cunningham | grad student | 2004 | UTHSC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tanratana P, Sachetto ATA, Mast AE, et al. (2023) An anti-tissue factor pathway inhibitor antibody increases tissue factor activity in extracellular vesicles isolated from human plasma. Research and Practice in Thrombosis and Haemostasis. 8: 102275 |
| Maroney SA, Siebert AE, Martinez ND, et al. (2022) Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice. Journal of Thrombosis and Haemostasis : Jth |
| Reitsma SE, Holle LA, Bouck EG, et al. (2022) Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency. Journal of Thrombosis and Haemostasis : Jth. 21: 467-479 |
| Mast AE, Ruf W. (2022) Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy. Journal of Thrombosis and Haemostasis : Jth |
| Peterson JA, Gupta S, Martinez ND, et al. (2021) Factor V east Texas variant causes bleeding in a three-generation family. Journal of Thrombosis and Haemostasis : Jth |
| Maroney SA, Westrick R, Cleuren A, et al. (2020) Tissue factor pathway inhibitor is required for cerebrovascular development in mice. Blood |
| Ellery PER, Hilden I, Thyregod P, et al. (2019) Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia. Haemophilia : the Official Journal of the World Federation of Hemophilia |
| Castillo MM, Yang Q, Zhan M, et al. (2019) Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency. Blood Advances. 3: 489-498 |
| Maroney SA, Peterson JA, Zwifelhofer W, et al. (2018) Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery. Thrombosis and Haemostasis |
| Thomassen S, Mastenbroek TG, Swieringa F, et al. (2018) Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength. Thrombosis and Haemostasis |